| Financial Year |
March 31 2023 |
| Monetary Funds |
759,134,658.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
16,408,500.67 |
| Advances to Suppliers |
22,357,725.75 |
| Other Receivables |
896,368.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
83,257,798.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,173,747,940.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
233,316,355.65 |
| Investment Properties |
-- |
| Fixed Assetes |
1,113,591,945.41 |
| Under-construction Projects |
3,832,207.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
339,469,304.28 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,298,023.02 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,757,007,835.58 |
| Total Assets |
2,930,755,776.07 |
| Short-Term Loans |
170,829,094.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
258,941,804.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,887,975.82 |
| Taxes Payable |
12,139,191.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,407,159.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
209,879,554.15 |
| Other Current Liabilities |
15,784,089.10 |
| Sub-Total of Current Liabilities |
813,080,231.31 |
| Long-term Loans |
404,023,594.91 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,366,957.83 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
13,116,306.00 |
| Sub-Total of Non-Current Liabilities |
425,299,889.07 |
| Total Liabilities |
1,238,380,120.38 |
| Paid-In Capital(Or Share Stock) |
464,145,765.00 |
| Capital Surplus |
1,181,006,630.94 |
| Surplus Reserve |
210,074,379.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-164,270,525.54 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,692,375,655.69 |
| Owner's Equity（Stockholder's Equity） |
1,692,375,655.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,930,755,776.07 |
